Design and evaluation of chitosan films for transdermal delivery of glimepiride

Current Drug Delivery

Volumn 5, Issue 4, 2008, Pages 290-298

  Ammar, H O ^a   Salama, H A ^a   El Nahhas, S A ^a   Elmotasem, H ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Chitosan; Cyclodextrins; Glimepiride; Penetration enhancers; Transdermal

Indexed keywords

ALCOHOL; BETA CYCLODEXTRIN; CHITOSAN; GLIMEPIRIDE; LIMONENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DIZZINESS; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG SAFETY; DRUG SOLUBILITY; DRUG TRANSPORT; FILM; HUMAN; INFRARED SPECTROSCOPY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RAT; STOMACH DISEASE; TENSILE STRENGTH; X RAY DIFFRACTION;

ADMINISTRATION, CUTANEOUS; ANIMALS; BETA-CYCLODEXTRINS; CHITOSAN; DRUG DELIVERY SYSTEMS; HYPOGLYCEMIC AGENTS; MALE; PERMEABILITY; RATS; RATS, WISTAR; SKIN; SOLUBILITY; SPECTROPHOTOMETRY, INFRARED; SULFONYLUREA COMPOUNDS; X-RAY DIFFRACTION;

EID: 55049111158     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720108785915005     Document Type: Article

References (66)

1. Kabadi, UM. Manag. Care, 2004, 13, 48.
2. Kouichi, I.; Masaki, W.; Youhei, N.; Takahiro, S.; Nobuki, T.; Masahiko, T.; Hideyuki, K.; Kensuke, Y.; Masao, S., Susumu, K.; Takuya A.; Shigehiro, K. Diabetes Res. Clin. Pract., 2005, 68, 250.
3. Thummel, K.E. Adv. Drug Deliv. Rev., 1997, 27, 97.
4. Frick, A.; Moller H.; Wirbitzki, E. Eur. J. Pharm. Biopharm., 1998, 46, 305.
5. Massimo, M.B. Clin. Ther., 2003, 25, 799.
6. Profozic V.L.; Metelko, Z.L. Dis. Manag. Health Outcomes, 1998, 4, 29.
7. Barry, B. W. Eur. J .Pharm. Sci., 2001, 14, 101.
8. Panchagnula, R., Ind. J. Pharm., 1997, 29, 140.
9. Takahashi, Y.; Furuya, K.; Iwata, M.; Onishi, H.; Machida, Y.; Shirotake, S. Yakugaku Zasshi, 1997, 117, 1022.
10. Takahashi, Y.; Iwata, M.; Machida, Y. Yakugaku Zasshi, 2001. 121, 161.
11. Mutalik, S.; Udupa, N. J. Pharm. Sci., 2004, 93, 1577.
12. Sridevi, S.; Diwan, P.V.R. Pharmazie, 2002, 57, 632.
13. Mutalik, S.; Udupa, N. Pharmazie, 2002, 57, 838.
14. Ammar, H.O; Salama, H.A.; Ghorab, M.; El-Nahhas S.; Elmotasem, H. Curr. Drug Deliv., 2006, 3, 333.
15. Zhang, Y.; Xu, D.H.; Ma, Z.; Chen, Y.; Zhao, J.J; Xu, S.B. Yao Xue Xue Bao., 2004, 39, 640.
16. Chae, Su.Y.; Jang, Mi.K.; Nah, J.W. J. Control. Release, 2005, 102, 383.
17. Paul, W.; Sharma, C.P. S.T.P. Pharm. Sci., 2000,10, 5.
18. Illum, L., Pharm. Res., 1998, 15, 1326.
19. Ranaldi, G.; Marigliano, I.; Vespignani, I.; Perozzi, G.; Sambuy, Y. J. Nutr. Biochem., 2002, 13, 157.
20. Schipper, N.G.M.; Olsson, S.; Hoogstraate, J.A.; deBoer, A.G.; Varum, K.M.; Artursson, P. Pharm. Res., 1997, 14, 923.
21. Schipper, N.G.M.; Varum, K.M.; Stenberg, P.; Ocklind, G.; Lennernas, H.; Artursson, P. Eur. J. Pharm. Sci., 1999, 8, 335.
22. Zerrouka, N; Menninib, N.; Maestrellib, F.; Chemtoba, C.; Murab, P. Eur. J. Pharm. Biopharm., 2004, 57, 93.
23. Foldvari, M. Pharm.Sci. Technol. Today., 2000, 3, 417.
24. Ammar, H.O.; Salama, H.A.; Ghorab M.; Mahmoud, A.A. Int. J. Pharm., 2006, 309, 129.
25. Ammar, H.O.; El-Nahhas, S.A. Pharmazie, 1995, 50, 408.
26. Loftsson, T.; Bodor, N. Effect of cyclodextrins on percutaneous transport of drugs. In: Smith, E.W.; Maibach, H.I., Eds, Percutaneous Penetration Enhancers. Florida. CRC Press, Boca Raton, 1995, pp. 335.
27. Mastuda, H.; Arima, H. Adv. Drug Deliv. Rev., 1999, 36, 81.
28. Lopez, R.F.; Colett, J.H.; Bently, M.V. Int. J. Pharm., 2000, 200, 27.
29. Martin, A.; Bustamante, P.; Chun A.H.C. Physical Pharmacy: Physical Chemical Principles in Pharmaceutical Sciences (forth ed.), Lippincott Williams & Wilkins, 1993, pp. 260.
30. Uekema, K.; Horiuchi Y.; Kikuchi M. J. Incl. Phenom., 1988, 6, 167.
31. El-Sabbagh, S.H.; Hussain A.I.; Abd El-Ghaffar, M.A. Pigment & Resin Technol., 2005, 4, 203.
32. Shah, V.P.; Tymes, N.W.; Yamamoto, L.A.; Skelly, J.P. Int. J. Pharm., 1986, 32, 243.
33. Vogel, H.G.; Vogel, W.H. Drug Discovery and Evaluation: Pharmacological Assays. Berlin. Springer - Verlag, 1997, pp. 570.
34. Stepensky, D.; Friedman, M.; Srour, W.; Raz, I.; Hoffman, A., J. Control. Release, 2001, 71, 107.
35. Pepato, M.T.; Keller, E.H; Baviera, A.M.; Kettelhut, I.C.; Vendarmini, R.C. J. Ethnopharmacol., 2002, 81, 191.
36. Gabra, P.H.; Sirois, P. Eur. J. Pharm., 2005, 514, 61.
37. Ladriere, L.; Malaisse-Lagae, F.; Fuhlendorff, J.; Malaisse, W.J. Eur. J. Pharm., 1997, 335, 227.
38. Wagner, S.G., Fundamentals of Clinical Pharmacokinetics (first ed.), Drug Intelligence Publications Inc., Hamilton, Illinois, 1975, pp. 7.
39. Knapczyk, J. Int. J. Pharm., 1993, 93, 233.
40. Lai, H.M.; Padua, G.W. Cereal. Chem., 1997, 74, 771.
41. Wu, C.; McGinity, J.W. Int. J. Pharm., 1999, 177, 15.
42. Peppas, N.A.; Buri, P.A. J. Control. Release, 1985, 2, 257.
43. Ahmad Khan, T.; Peh, K. K.; Ching, H. S. Pharm. Pharmaceut. Sci., 2000, 3, 303.
44. Kurozumi, M.; Nambu, N.; Nagai, T. Chem. Pharm. Bull., 1975, 23, 3062.
45. Ozkana, Y.; Ataya, T.; Dikmena, N.; Işimera, A.; Aboul-Enein, H.Y. Pharm. Acta Helv., 2000, 74, 365.
46. Fernandes, M.; Vieira M.T.; Veigaa, F. Eur. J. Pharm. Sci., 2002, 15, 79.
47. Jug, M.; Becirevic-Lacan, M. Eur. J. Pharm. Sci., 2004, 21, 251.
48. Ryan, J.A. J. Pharm. Sci., 1986, 75, 805.
49. McCrum, N.G., Buckley, C.P., Bucknall, C.B. (Eds).Principles of Polymer Engineering. Oxford University Press, New York, 1988, pp. 18.
50. Loftsson, T.; Massom, M. Int. J. Pharm. 2001, 225, 15.
51. Larrucea, E.; Arellan, A.; Santoyo, S.; Ygartu, P. Drug Dev. Ind. Pharm., 2002, 28, 245.
52. Sridevi, S.; Diwan, P.V.R. Eur. J. Pharm. Biopharm., 2002, 54, 151.
53. Uekama, K.; Hirayama, F.; Irie T. Chem. Rev., 1998, 98, 2045.
54. Williams, A.C.; Barry, B.W. Adv. Drug Deliv. Rev., 2004, 56, 603.
55. Loftsson, T.; Olafsson, J.H. Int. J. Dermatol., 1998, 37, 241.
56. Meidan, M.V.; Docker, M.; Walmsley A.D.; Irwin, W.J. Pharm. Res., 1998, 15, 85.
57. Illel, H.; Schaefer, J.; Wepierre, J.; Doucet, O. J. Pharm. Sci., 1991, 80, 424.
58. Li, S.K.; Suh, W.; Parikh, H.H.; Ghanem, A.H.; Mehta, S.C.; Peck, K.D.; Higuchi W.I. Int. J. Pharm., 1998, 170, 93.
59. Preiss, A.; Mehnert, W.; Fromming, KH. Pharmazie, 1995, 50, 121.
60. Williams, A.C.; Barry, B.W. Int. J. Pharm., 1991, 74, 157.
61. Cornwell, P.A.; Barry, B.W. Int. J. Pharm., 1993, 94, 189.
62. Okabe, H.; Takayama, K.; Ogura, A.;Nagai T. Drug Des. Deliv., 1989, 4, 313.
63. Nagai, T.; Okabe, H.; Ogura, A.; Takayama, K. Effect of limonene and related compounds on the percutaneous absorption of indomethacin. In: Proceedings of the 16th International Symposium on Controlled Release Bioactive Material, Chicago, USA. 1989, pp. 181.
64. Berner, B.; Mazzenga, G.C; Otte, J.H.; Steffens. R.J.; Juang R.H.; Ebert, C.D. J. Pharm. Sci., 1989, 78, 402.
65. Pershing, L.K.; Lambert, L.D.; Knutson, K. Pharm. Res., 1990, 7, 170.
66. Megrab, N.A.; Williams A.C.; Barry, B.W. Int. J. Pharm., 1995, 116, 101.